Pies o Manos Ardientes

D-ribose's documented role in restoring myocardial ATP and improving diastolic function in heart failure patients has indirect relevance to heart rhythm, since ATP depletion and diastolic dysfunction are associated with arrhythmia risk. Clinical evidence directly targeting rhythm outcomes with D-ribose is limited; the data derive primarily from hemodynamic improvements in CHF trials.

Berberine from barberry has documented anti-arrhythmic effects, reducing ventricular premature beats and tachycardia in experimental and some clinical studies. The mechanism involves ion channel modulation. This is considered an established pharmacological property of berberine.

Berberine is an isoquinoline alkaloid from plants such as Coptis chinensis with well-characterized antiarrhythmic electrophysiological actions, including potassium channel blockade, action potential prolongation, and effective refractory period extension. In 24–48-hour Holter monitoring of 100 patients with ventricular tachyarrhythmia, berberine produced ≥50% reduction in VPCs in 62% of patients. A retrospective study compared berberine vs amiodarone for paroxysmal AF (45 vs 43 patients), showing comparable conversion rates with improved echocardiographic parameters.

Bovine heart provides taurine and CoQ10, both of which have documented roles in cardiac electrophysiology. Taurine modulates calcium handling and membrane excitability in cardiomyocytes; CoQ10 has been investigated as an adjuvant in atrial fibrillation. Evidence comes from constituent-level studies, not bovine heart capsule trials.

Accumulating pharmacological and clinical evidence indicates Danshen and its components have anti-arrhythmic properties. Tanshinone IIA and other constituents modulate cardiac ion channels and suppress arrhythmia in experimental and some clinical settings.

CoQ10 is a mitochondrial electron carrier reduced in heart disease; its depletion is linked to arrhythmia risk. A meta-analysis of 8 RCTs found cardiac surgery patients treated with CoQ10 were significantly less likely to develop ventricular arrhythmias (OR 0.05, 95% CI 0.01–0.31). Proposed mechanisms include improved cellular energy production, membrane stabilization, and reduced ischemia-induced arrhythmogenesis.

D-Ribose is a pentose sugar essential for ATP synthesis; cardiac energy depletion can impair impulse conduction and trigger arrhythmias. A patent-backed clinical case series (US Patent 8,101,581; EP2120968B1) reported that D-ribose 5–15 g/day reduced or prevented atrial fibrillation occurrence in eight patients. Its mechanism involves restoring myocardial ATP, supporting normal electrical conduction.

Danshen (Salvia miltiorrhiza) is a traditional Chinese medicine herb whose active components (tanshinone, salvianolic acid) have demonstrated electrophysiological and antiarrhythmic effects. Clinical evidence shows Danhong Injection (Danshen + safflower) reduces QT dispersion in patients with ventricular premature contraction from coronary disease and prevents malignant arrhythmia. Danshen preparations are used in Chinese clinical practice for palpitations and cardiac rhythm disorders.

DHA demonstrably reduces resting heart rate and modulates heart rate variability (HRV) in clinical studies, effects considered favorable for cardiac autonomic health. Multiple RCTs show DHA is more effective than EPA at lowering heart rate. However, at high doses, omega-3 supplementation has been associated with increased atrial fibrillation (AF) risk.

Fish oil has complex and partially conflicting evidence regarding cardiac arrhythmias. Mechanistically, EPA and DHA stabilize cardiac ion channels and have anti-arrhythmic properties demonstrated in animal models and early human studies. However, large RCTs have not confirmed a reduction in atrial fibrillation risk, and high-dose fish oil supplements may paradoxically increase AF risk in some populations.

Animal studies demonstrate flaxseed diet significantly reduces ventricular fibrillation during cardiac ischemia/reperfusion compared to controls. A 2018 American Journal of Physiology review specifically documented antiarrhythmic effects as part of flaxseed's cardiovascular benefits, though clinical human data on arrhythmia endpoints are limited.

Berberine, present in goldenseal, has been investigated for antiarrhythmic properties, and preliminary evidence suggests benefit in congestive heart failure with ventricular arrhythmias. ConsumerLab notes preliminary evidence that berberine may benefit people with congestive heart failure, while also flagging that berberine has been reported to trigger abnormal heart rhythm in some individuals.

Hawthorn (Crataegus spp.) extract has demonstrated antiarrhythmic effects in laboratory, animal, and real-world clinical studies. A large German retrospective cohort study (n=9,000+ patients) found hawthorn extract WS 1442 was significantly associated with lower incidence of atrial fibrillation/flutter, tachycardia, and other cardiac arrhythmias versus controls. Its flavonoids and oligomeric procyanidins prolong cardiac action potential and refractory period.

L-carnitine has documented anti-arrhythmic properties supported by clinical evidence. The meta-analysis in acute MI patients (DiNicolantonio 2013) showed a 65% reduction in ventricular arrhythmias with L-carnitine vs. control. A PubMed review (2018) lists cardiac arrhythmia as a target condition for L-carnitine administration.

A randomised, placebo-controlled clinical trial demonstrated that 500 mg of lemon balm twice daily for 2 weeks significantly reduced the frequency of heart palpitation episodes and reduced the proportion of anxious patients versus placebo. Animal data also show mild protection against reperfusion-induced ventricular arrhythmias. The proposed mechanism involves ACE inhibition and GABA-mediated autonomic calming.

Bisbenzylisoquinoline alkaloids of the lotus seed embryo—neferine, liensinine, and isoliensinine—have demonstrated anti-arrhythmic effects in animal models, antagonizing arrhythmias induced by aconitine, calcium chloride, and coronary occlusion-reperfusion. No human arrhythmia trials exist.

Magnesium is a well-established cofactor in cardiac electrophysiology, modulating ion channel exchanges and action potentials. Hypomagnesemia is strongly linked to ventricular and supraventricular arrhythmias. A meta-analysis of 22 studies found magnesium sulfate significantly reduced both ventricular arrhythmias (11.88% vs 24.24%) and supraventricular arrhythmias compared to placebo. Intravenous magnesium is a recognized treatment for torsades de pointes, digitalis-induced arrhythmias, and multifocal atrial tachycardia.

Motherwort (Leonurus cardiaca) has been used since the 15th century in European and Asian traditional medicine for palpitations, tachyarrhythmias, and nervous cardiac disorders. Its constituents leonurine, stachydrine, and flavonoids inhibit inward calcium and potassium channels, prolong Q-T and P-Q intervals, and slow pacemaker activity in electrophysiological studies. The EMA recognizes its traditional use for mild arrhythmias related to anxiety.

Omega-3 polyunsaturated fatty acids (EPA+DHA) have been studied extensively for antiarrhythmic effects, with proposed mechanisms including membrane ion channel modulation and reduced cardiac excitability. Earlier smaller RCTs found reductions in post-operative atrial fibrillation; however, more recent large meta-analyses of 81,210 patients across seven trials found a dose-dependent complexity, with higher doses (>1g/day) associated with increased AF risk in some studies.

Ophiopogon japonicus extracts affect the electrophysiological characteristics of myocardium and have demonstrated antiarrhythmic effects in preclinical and formula-level clinical research. Shengmai-based formulas have been shown to reduce arrhythmia occurrence in clinical reports. Ruscogenin and water extracts of the root are implicated mechanically.

Ophiopogon root water extracts have documented antiarrhythmic effects on myocardial electrophysiology in preclinical models. Clinical evidence derives from multi-herb formulas including O. japonicus: Shenmai and Shengmai injections are documented to reduce arrhythmia occurrence in heart failure and cardiotoxicity settings across multiple clinical reports. The TCM classification also includes arrhythmia and palpitations as core indications.

Preclinical studies in isolated rat heart models demonstrate that P. tenuifolia extract exerts antiarrhythmic effects against ischemia-reperfusion-induced arrhythmia, with cardioprotective potency comparable to tetrandrine and superior in some measures to verapamil. The Polygalae Radix overview lists antiarrhythmic effects as a documented pharmacological activity.

Potassium is critical for cardiac electrical conduction; hypokalemia increases risk of ventricular and supraventricular arrhythmias. The randomized POTCAST trial (n=1,200 ICD patients) demonstrated that targeting high-normal plasma potassium reduced unplanned hospitalizations for cardiac arrhythmias (6.7% vs 10.7%, HR 0.63) and appropriate ICD therapy. Potassium supplementation is a standard clinical approach to arrhythmia prevention.

Taurine is a sulfur-containing amino acid that modulates cardiac ion channels, calcium signaling, and membrane potential stability. Animal and clinical evidence shows taurine reduces arrhythmia occurrence; it is approved for congestive heart failure treatment in Japan. A case-history study (published Med Hypotheses, 2006) reported oral taurine (10–20 g/day) reduced PACs by 50% and eliminated PVCs in patients with frequent irregular heartbeats.

Thiamine deficiency-induced cardiac beriberi causes characteristic tachycardia as part of high-output heart failure, and thiamine repletion restores normal heart rate. Thiamine supports autonomic nervous system function and myocardial energy metabolism that underpin normal cardiac rhythm.

Biota seed has been used in TCM for over 2,000 years specifically for palpitations—irregular or rapid heartbeats perceived as distressing. It is recorded in Shen Nong's Herbal Classic for calming palpitations and is a core indication in Heart-nourishing formulas. There is no clinical or controlled scientific evidence validating this use in humans.